Behavior and knowledge survey to assess the effectiveness of educational materials among healthcare professionals who prescribe AUBAGIO® (teriflunomide) (cross-sectional survey)

30/05/2020
14/03/2024
EU PAS number:
EUPAS31013
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

TERIFC09616_Wave 1 - protocol hcp - Aubagio

English (158.31 KB - PDF) View document
Updated protocol

TERIFC09616_Wave 2 - protocol hcp - Aubagio

First published: 22/02/2024
English (336.41 KB - PDF) View document
Study results
Study results

Aubagio HCP Wave 1 and 2 combined report-Final

English (467.5 KB - PDF) View document
Study report
Other information